Capital World Investors 13D and 13G filings for Fate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 6:19 pm Sale |
2024-02-07 | 13G | Fate Therapeutics, Inc. FATE |
Capital World Investors | 0 0.000% |
-5,591,517 (Position Closed) |
Filing |
| 2023-02-13 2:49 pm Purchase |
2023-02-14 | 13G | Fate Therapeutics, Inc. FATE |
Capital World Investors | 5,591,517 5.800% |
5,591,517 (New Position) |
Filing |